F-STAR THERAPEUTICS INC (FSTX) Stock Income Statement
NASDAQ:FSTX - Nasdaq - US30315R1077 - Common Stock - Currency: USD
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 21.18M | 21.17M | 11.26M | 0.00 | 0.00 | |||
| Operating Expenses | 57.93M | 51.88M | 33.64M | 33.02M | 28.47M | |||
| Research and Development | 34.65M | 28.75M | 14.13M | 23.27M | 19.75M | |||
| Selling, General, and Administrative Expenses | 23.28M | 23.13M | 19.51M | 9.75M | 8.72M | |||
| Operating Income | -36.75M | -30.71M | -22.39M | -33.02M | -28.47M | |||
| Interest Income/Expense | -8.68M | -255.00K | N/A | 710.00K | 1.00M | |||
| Other Income/Expense | 118.00K | -686.00K | -3.24M | 8.21M | 4.62M | |||
| Non Recurring Items | N/A | N/A | 0.00 | N/A | N/A | |||
| Income Before Taxes | -45.31M | -31.66M | -25.62M | -24.10M | -22.85M | |||
| Income Tax | -562.00K | -372.00K | 0.00 | N/A | N/A | |||
| Net Income | -44.75M | -31.28M | -25.62M | -24.10M | -22.85M | |||
| EBITDA | -36.08M | -30.07M | -21.25M | -32.66M | -28.18M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.07 | -1.88 | -9.69 | -5.86 | -6.36 | |||
| Non GAAP EPS | -1.81 | -2.01 | -6.54 | -5.88 | -6.36 | |||
| Statistics | ||||||||
| Profit Margin | -211.32% | -147.79% | -227.53% | N/A | N/A | |||
| Operating Profit Margin | -173.56% | -145.10% | -198.85% | N/A | N/A | |||
All data in USD